Ten years of laboratory diagnosis of HIV: How accurate is it now?

被引:1
作者
Mortimer, PP
机构
关键词
D O I
10.1093/jac/37.suppl_B.27
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The high expectations of laboratory diagnosis of HIV have mostly been met, but some problems remain. Current tests for anti-HIV antibodies are sensitive enough for many purposes, but for earliest diagnosis direct tests for virus are necessary. False negative results may occur, for instance because infection with virus variants such as HIV 1 subtype O is not recognised, or because of laboratory or clerical error. The laboratory monitoring of mothers and babies who have been treated with zidovudine, to establish whether perinatal infection has taken place will be difficult, and more reliable quantitative assays of HIV are needed to measure the risk of transmission from mother to baby. Proposals to introduce home testing for HIV may improve ascertainment of infection, but there must first be adequate support in place for those individuals who find themselves HIV-positive. Quality assurance, especially through clinical and laboratory audit, may now add more to diagnostic accuracy than the development of even more sensitive assays. The outstanding challenge is to make universally available tests with the accuracy and consistency achieved when best laboratory practice is enforced.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 10 条
[1]   TESTING FOR HIV-INFECTION AT HOME [J].
BAYER, R ;
STRYKER, J ;
SMITH, MD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (19) :1296-1299
[2]   CLEARANCE OF HIV-INFECTION IN A PERINATALLY INFECTED INFANT [J].
BRYSON, YJ ;
PANG, S ;
WEI, LS ;
DICKOVER, R ;
DIAGNE, A ;
CHEN, ISY .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (13) :833-838
[3]   TIME-COURSE OF DETECTION OF VIRAL AND SEROLOGIC MARKERS PRECEDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERSION - IMPLICATIONS FOR SCREENING OF BLOOD AND TISSUE DONORS [J].
BUSCH, MP ;
LEE, LLL ;
SATTEN, GA ;
HENRARD, DR ;
FARZADEGAN, H ;
NELSON, KE ;
READ, S ;
DODD, RY ;
PETERSEN, LR .
TRANSFUSION, 1995, 35 (02) :91-97
[4]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[5]  
DECOCK KM, 1994, AIDS S, V8, P585
[6]   ERROR CONTRIBUTES TO THE RISK OF TRANSMISSIBLE DISEASE [J].
LINDEN, JV .
TRANSFUSION, 1994, 34 (11) :1016-1016
[7]  
MCALPINE L, 1995, J CLIN PATHOL, V48, P1
[8]  
MOKILI LK, 1995, IN PRESS CLIN DIAGNO
[9]   GACPAT HIV-1+2 - A SIMPLE, INEXPENSIVE ASSAY TO SCREEN FOR, AND DISCRIMINATE BETWEEN, ANTI-HIV-1 AND ANTI-HIV-2 [J].
PARRY, JV ;
CONNELL, JA ;
REINBOTT, P ;
GARCIA, AB ;
AVILLEZ, F ;
MORTIMER, PP .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (01) :10-16
[10]   DURATION OF TIME FROM ONSET OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTIOUSNESS TO DEVELOPMENT OF DETECTABLE ANTIBODY [J].
PETERSEN, LR ;
SATTEN, GA ;
DODD, R ;
BUSCH, M ;
KLEINMAN, S ;
GRINDON, A ;
LENES, B .
TRANSFUSION, 1994, 34 (04) :283-289